SCHEMBL4195064

SCHEMBL4195064

O=C1NC(c2ccccc2)C(=O)O1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.42
KMT2A Q03164 2/20 0.42
ALDH1A1 P00352 2/20 0.42
GAA P10253 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
GFER P55789 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CA2 P00918 1/20 0.41
LMNA P02545 2/20 0.41
MEN1 O00255 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
USP2 O75604 1/20 0.38
MAPK10 P53779 1/20 0.38
TSHR P16473 1/20 0.37
TNKS2 Q9H2K2 1/20 0.36
PRCP P42785 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4195063 1.00 MAPT (0.42) MAPTKMT2AALDH1A1GAAKDM4E
SCHEMBL11265304 0.98 MAPT (0.41) MAPTKMT2AALDH1A1GAAKDM4E
SCHEMBL164001 0.80 TDP1 (0.50) KMT2AGAAPRCP
SCHEMBL31357816 0.77 KMT2A (0.65) MAPTKMT2AALDH1A1GAAKDM4E
SCHEMBL29965150 0.77 MAPT (0.65) MAPTKMT2AALDH1A1GAAKDM4E
SCHEMBL7218139 0.72 IDO1 (0.38)
SCHEMBL31357782 0.71 LMNA (0.42) MAPTKMT2AALDH1A1KDM4EHSD17B10
Methane SCHEMBL11336749 0.70 MAPT (0.48) MAPTKMT2AALDH1A1GAAKDM4E
SCHEMBL1895535 0.70 MAPT (0.48) MAPTKMT2AALDH1A1GAAKDM4E
SCHEMBL1894049 0.70 MAPT (0.48) MAPTKMT2AALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4489208-A Process for producing D(-)mandelic acid E.N.I. NAZIONALE IDROCARBURI (IT) 1984-12-18 US claimed
WO-2024028255-A1 POLY(AMINO ACID) BASED CAPSULES AGFA-GEVAERT NV (BE) 2024-02-08 WO disclosed
US-20150060361-A1 DRAW SOLUTES INCLUDING AMINO ACID IONIC OLIGOMERS LOTTE CHEMICAL CORPORATION (KR) 2015-03-05 US disclosed
US-7498431-B2 Process for the preparation of chiral azetidinones FRAMROZE BOMI PATEL 2009-03-03 US disclosed
US-7482368-B2 Triamide-substituted heterobicyclic compounds PFIZER INC (US) 2009-01-27 US disclosed
EP-1404653-B1 TRIAMIDE-SUBSTITUTED INDOLES, BENZOFURANES AND BENZOTHIOPHENES AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN (MTP) AND/OR APOLIPOPROTEIN B (APO B) SECRETION PFIZER PROD INC (US) 2008-08-20 EP disclosed
US-7348355-B2 Treating obesity with the Microsomal triglyceride transfer protein inhibitor (S) N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide and another lipid lowering agent such as a statin or fibrate PFIZER INC. (US) 2008-03-25 US disclosed
US-20070129540-A1 Process for the preparation of chiral azetidinones OPUS ORGANICS PVT LIMITED (IN) 2007-06-07 US disclosed
US-20060194772-A1 Triamide-substituted heterobicyclic compounds PFIZER INC 2006-08-31 US disclosed
US-7002008-B2 Process for the preparation of 1-(4-fluorophenyl)-4(S)-(4-hydroxyphenyl)-azetidin-2-one FRAMROZE BOMI PATEL 2006-02-21 US disclosed
US-5744471-A NERVOUS SYSTEM DISORDERS ZENECA LIMITED (GB) 1998-04-28 US disclosed
CN-1171787-A Pyridazinoquinoline compounds ZENECA LTD (GB) 1998-01-28 CN disclosed
EP-0790996-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1997-08-27 EP disclosed
CN-1138332-A Pyridazinoquinoline compounds ZENECA LTD (GB) 1996-12-18 CN disclosed
EP-0724583-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-08-07 EP disclosed
WO-1996015127-A1 PYRIDAZINOQUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1996-05-23 WO disclosed
WO-1995011244-A1 PYRIDAZINO QUINOLINE COMPOUNDS ZENECA LIMITED (GB) 1995-04-27 WO disclosed
US-4489208-A Process for producing D(-)mandelic acid E.N.I. NAZIONALE IDROCARBURI (IT) 1984-12-18 US disclosed
US-4332905-A STEREOSELECTIVE ENZYMATIC HYDROLYSIS OF RACEMIC 5-SUBSTITUTED 2,4-OXAZOLIDINEDIONES E.N.I. ENTE NOZIONALE IDROCARBURI (IT) 1982-06-01 US disclosed
US-4314023-A AZO-METHINE DYES KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1982-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060194772-A1 Triamide-substituted heterobicyclic compounds APOB, LIPC, MTTP MAPT 3447/4885KMT2A 2232/4885ALDH1A1 3734/4885
US-20070129540-A1 Process for the preparation of chiral azetidinones CYP1B1, ALDH7A1, CYP3A5 MAPT 4388/4885KMT2A 4551/4885ALDH1A1 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.